Shelby Terstriep MD
Shelby Terstriep, MD, is a board-certified physician specializing in hematology, medical oncology, and palliative medicine at Roger Maris Cancer Center. She is also the enterprise medical director of Cancer Survivorship at Sanford Health.
Dr. Terstriep joined Sanford Health in 2007 and quickly made her mark on the organization through her innovative, creative, and business-savvy approach to medical care. She specializes in breast cancer and survivorship care and led the development of Sanford Health’s cancer survivorship program, which, since its launch in 2008, has become the organization’s leading survivorship program. The goal is to create an innovative program to meet the physical, emotional, spiritual, and psychological needs of every cancer survivor. She continues to serve as enterprise medical director for the program, in addition to her doctoral duties within the cancer center. Dr. Terstriep is board-certified in internal medicine, hematology, oncology, and palliative medicine and is a clinical associate professor at the University of North Dakota.
Dr. Terstriep’ s passion to improve care for cancer patients was recognized in 2011 with the American Cancer Society’s Lane Adams Quality of Life Award, an award given to only 11 caregivers nationally each year. In 2013, she received Sanford Health’s Innovator Award because of the work she is doing to improve the patient experience. She is active in research, serving on national committees to improve quality of life and healthcare outcomes. She designed, and is currently leading, a clinical trial evaluating nutritional interventions to improve breast cancer outcomes. She is a member of ASCO and serves on two of its committees: Integrative Media and Technology and the Workforce Advisory Group. In addition, she is a medical correspondent for Valley News Live’s North Dakota Today show.
She is a highly connected physician who is passionate about innovation in care delivery and translating the complicated foreign language of health and medicine into everyday language, as well as enhancing the quality of life for cancer survivors.